SCFAs could protect mice against colitis by modulating colonic Treg number and activity in a GPR43-dependent manner [58], because GPR43-deficient (Gpr43(−/−)) mice showed unresolving or exacerbated inflammation in models of colitis [26]. Here, FFAR2 is linked to colitis.